Skip to content Skip to footer
Catalyst Health Ventures
1 800 458 56 97
Investor Portal
Investor Portal
Close

Portfolio

Investing in exceptional teams and companies shaping the future of healthcare
Acquired By:
Veracyte (NASDAQ: VCYT)
Acquired By:
Veracyte (NASDAQ: VCYT)
ARIA CV
Atacor Medical
Acquired By:
Boston Scientific (NYSE: BSX)
Acquired By:
Boston Scientific (NYSE: BSX)
Avive
Acquired By:
Agilent Technologies (NYSE: A)
Acquired By:
Agilent Technologies (NYSE: A)
Acquired By:
Life Technologies (NYSE: TMO)
Acquired By:
Life Technologies (NYSE: TMO)
Brixton
Conformal
Acquired By:
W. L. Gore & Associates
Acquired By:
W. L. Gore & Associates
Epitel
Esperto Medical
Eyecool
Initial Public Offering:
ASX: GID
Initial Public Offering:
ASX: GID
Acquired By:
Sun Life Financial (NYSE: SLF)
Acquired By:
Sun Life Financial (NYSE: SLF)
Acquired By:
Boston Scientific (NYSE: BSX)
Acquired By:
Boston Scientific (NYSE: BSX)
Rejoni
Acquired By:
Fortune 500 Company
Acquired By:
Fortune 500 Company
Initial Public Offering:
NASDAQ: SERA
Initial Public Offering:
NASDAQ: SERA
Acquired By:
Medline (NASDAQ: MDLN)
Acquired By:
Medline (NASDAQ: MDLN)
Venova
Acquired By:
AngioDynamics (NASDAQ: ANGO)
Acquired By:
AngioDynamics (NASDAQ: ANGO)

Featured News

Stay up to date with the latest investments, insights and industry developments

Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System

Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular

Have a game-changing idea or looking to collaborate?

Let’s Start the Conversation

Connect